SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005749
Filing Date
2020-05-07
Accepted
2020-05-07 16:33:03
Documents
87
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q chrs-20200507x10q.htm   iXBRL 10-Q 1965110
2 EX-10.4 chrs-20200331xex10d4.htm EX-10.4 39882
3 EX-31.1 chrs-20200331xex31d1.htm EX-31.1 12833
4 EX-31.2 chrs-20200331xex31d2.htm EX-31.2 13603
5 EX-32.1 chrs-20200331xex32d1.htm EX-32.1 10757
6 GRAPHIC chrs-20200331xex10d4001.jpg GRAPHIC 4152
  Complete submission text file 0001558370-20-005749.txt   8045968

Data Files

Seq Description Document Type Size
7 EX-101.SCH chrs-20200507.xsd EX-101.SCH 65716
8 EX-101.CAL chrs-20200507_cal.xml EX-101.CAL 89199
9 EX-101.DEF chrs-20200507_def.xml EX-101.DEF 211176
10 EX-101.LAB chrs-20200507_lab.xml EX-101.LAB 540866
11 EX-101.PRE chrs-20200507_pre.xml EX-101.PRE 421055
89 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20200507x10q_htm.xml XML 1349496
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36721 | Film No.: 20857008
SIC: 2836 Biological Products, (No Diagnostic Substances)